About

Dr. Woo Jung Lee is a pioneering robotic surgeon whose work has fundamentally reshaped minimally invasive oncology. His research centers on the application of robotic platforms—particularly the da Vinci system—to complex abdominal and pelvic cancers, with a focus on colorectal, hepatobiliary, and pancreatic malignancies. Dr. Lee’s landmark 2008 pilot randomized trial on robotic tumor-specific mesorectal excision for rectal cancer (303 citations) established a new standard for precision in colorectal surgery, demonstrating superior short-term outcomes. He further advanced the field through seminal studies on robotic spleen-preserving pancreatectomy (222 citations) and robotic liver resection (154 citations), proving that robotic assistance offers tangible clinical advantages over conventional laparoscopy. His work on transoral robotic surgery for laryngeal and hypopharyngeal cancer (151 citations) expanded the technology’s reach into head and neck oncology, promoting organ preservation. With over 1,500 total citations across his most-cited works, Dr. Lee’s contributions have been instrumental in defining the “Yonsei criteria” for minimally invasive pancreatic cancer surgery and in championing robotic hepatectomy in Korea. His career exemplifies how surgical innovation can improve oncologic outcomes while reducing patient morbidity.

Research Focus

Key Achievements

28
H-Index
55
Papers
2,649
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Robotic tumor-specific mesorectal excison of rectal cancer: short-term outcome of a pilot randomized trial
303 citations · 2008
📈 Most Prolific Year: 2007 (7 Papers)
🤝 Key Collaborators: 100
🏛 Institutions: Yonsei University, University Health System, Yonsei University Health System, National Yang Ming Chiao Tung University, Severance Hospital, Cancer Clinic

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago